Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 1, 2006, Pages 243-249

  Andes, D ^a,b   Craig, W A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; ERYTHROMYCIN; MACROLIDE; METICILLIN; PENICILLIN G; STREPTOGRAMIN; UNCLASSIFIED DRUG; XRP 2868;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; GRAM POSITIVE COCCI; LIQUID CHROMATOGRAPHY; LUNG INFECTION; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYOSITIS; NEUTROPENIA; NONHUMAN; PENICILLIN RESISTANCE; PHARMACODYNAMICS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THIGH;

ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BACTERIA; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUG EVALUATION; LUNG; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; STREPTOGRAMIN A; STREPTOGRAMIN B; STREPTOGRAMINS; THIGH;

EID: 29944436840     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.1.243-249.2006     Document Type: Article

References (13)

1. Carbon, C. 1998. Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens. Clin. Infect. Dis. 27:28-32.
2. Chin, N. X., and H. C. Neu. 1992. Postantibiotic effect of the new streptogramin RP 59500. Eur. J. Clin. Microbiol. Infect. Dis. 11:642-645.
3. Craig, W. A. 1998. Pharmacokinetics and pharmacodynamics of antibiotics in mice and men. Clin. Infect. Dis. 26:1-12.
4. Craig, W. A., and S. Ebert. 1993. Pharmacodynamic activities of RP 59500 in an animal infection model. Abstr. 34th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 470, 1993.
5. Craig, W. A., and S. Gudmundsson. 1996. Postantibiotic effect, p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
6. Craig, W. A., and B. Suh. 1996. Protein binding and the antimicrobial effects: methods for the determination of protein binding, p. 367-402. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams and Wilkins Co., Baltimore, Md.
7. Fantin, B., R. Leclercq, Y. Merle, et al. 1995. Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 in experimental endocarditis due to Staphylococcus aureus. Antimicrob. Agents Chemother. 39:400-405.
8. Goldstein, E. J. C., D. M. Citron, C. V. Merriam, Y. A. Waren, K. L. Tyrrell, H. T. Fernandez, and A. Bryskier. 2005. Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomyces, and lactobacilli. Antimicrob. Agents Chemother. 49:408-413.
9. Leggett, J. E, B. Fantin, S. Ebert, K. Totsuka, B. Vogelman, W. Calamae, H. Mattie, and W. A. Craig. 1989. Comparative antibiotic dose-effect relationships at several dosing intervals in murine pneumonitis and thigh-infection models. J. Infect. Dis. 159:281-292.
10. Nougayrede, A., N. Berthaud, and D. H. Bouanchaud. 1992. Post-antibiotic effect of RP 59500 on Staphylococcus aureus. J. Antimicrob. Chemother. 30(Suppl. A):101-106.
11. Pankuch, G. A., L. M. Kelly, G. Lin, A. Bryskier, C. Couturier, M. R. Jacobs, and P. C. Appelbaum. 2003. Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and Haemophilus species. Antimicrob. Agents Chemother. 47:3270-3274.
12. Rybak, M. J., H. H. Houlihan, R. C. Mercier, and G. W. Kaatz. 1996. Pharmacodynamics of quinupristin/dalfopristin administered by intermittent versus continuous infusion against Staphylococcus aureus infected fibrin-platlet clots in an in vitro infection model. Abstr. 36th Intersci. Conf. Antimicrob. Agents Chemother., abstr. A43, 1996.
13. Vesga, O., D. Andes, and W. A. Craig. 1996. In vivo pharmacodynamic activity of synercid against multiple bacterial pathogens. Abstr. 36th Intersci. Conf. Antimicrob. Agents Chemother., abstr. A42, 1996.